Toothy heroes in a half-shell
27 November, 2008 by Kate McDonaldEarliest known turtle fossils shed light on shell development
Arana's pilot for arthritis
26 November, 2008 by Kate McDonaldArana to run dosage trial for rheumatoid arthritis application
Avexa completes “jewel” recruitment
26 November, 2008 by Kate McDonaldAvexa concludes recruitment for Phase III, reducing cash burn
Uncovering the parasite metabolome
24 November, 2008 by Kate McDonaldHow metabolomics took on scientist from studying Antarctic microbiology to tropical parasitology.
Drastic cost-cutting at Benitec
20 November, 2008 by Kate McDonaldBenitec retrenches staff to reduce cash burn
Xenome gets acute
19 November, 2008 by Kate McDonaldXenome licenses IP for acute pancreatitis peptides
Cancer drugs reverse diabetes in mice
18 November, 2008 by Kate McDonaldTyrosine kinase inhibitors reverse type 1 diabetes in mice
Cytopia zeroes in on brain
17 November, 2008 by Kate McDonaldCytopia commences efficacy trial dosing for VDA in brain cancer
Asian flu study a MARVEL
17 November, 2008 by Kate McDonaldBiota’s next-generation flu treatment moves into Phase III
Strains and sprains for Phosphagenics
17 November, 2008 by Kate McDonaldPhosphagenics opens Phase I trial of topical NSAID for inflammation
Biotech briefs
14 November, 2008 by Kate McDonaldPhosphagenics, Patrys, Novogen, Stem Cell Sciences, Mesoblast
Arana reports strong cash position
12 November, 2008 by Staff WritersArana reports $181m cash, announces acting CEO
Cash for proof of concept
11 November, 2008 by Kate McDonaldProstate cancer diagnostic and phages for chooks win grants
Cotton steps for Hexima
10 November, 2008 by Staff WritersHexima signs project with CSIRO for fungal resistance in cotton
Anadis in Merck Phase IV study
23 October, 2008 by Staff WritersAnadis’ oral therapy in combination with Merck anti-AIDS drug in Phase IV trial
